In recent trading session, Capricor Therapeutics Inc (NASDAQ:CAPR) saw 0.55 million shares changing hands at last check today with its beta currently measuring 4.01. Company’s recent per share price level of $6.36 trading at -$0.52 or -7.56% at last check today assigns it a market valuation of $199.70M. That most recent trading price of CAPR’s stock is at a discount of -29.25% from its 52-week high price of $8.22 and is indicating a premium of 57.86% from its 52-week low price of $2.68. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.49 million shares which gives us an average trading volume of 264.73K if we extend that period to 3-months.
Capricor Therapeutics Inc (NASDAQ:CAPR) trade information
Upright in the red during last session for losing -7.56%, in the last five days CAPR remained trading in the red while hitting it’s week-highest on Tuesday, 03/19/24 when the stock touched $6.36 price level, adding 11.91% to its value on the day. Capricor Therapeutics Inc’s shares saw a change of 30.06% in year-to-date performance and have moved -0.47% in past 5-day. Capricor Therapeutics Inc (NASDAQ:CAPR) showed a performance of 63.92% in past 30-days. Number of shares sold short was 2.7 million shares which calculate 16.22 days to cover the short interests.
Capricor Therapeutics Inc (CAPR) estimates and forecasts
Statistics highlight that Capricor Therapeutics Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company added 16.70% of value to its shares in past 6 months, showing an annual growth rate of 0.00% while that of industry is 18.00. This year revenue growth is estimated to rise 13.30% from the last financial year’s standing.
3 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $9.7 million for the same. And 3 analysts are in estimates of company making revenue of $4.41 million in the next quarter that will end on Jun 2024. Company posted $2.99 million and $3.92 million of sales in current and next quarters respectively a year earlier. Analysts are expecting this quarter sales to grow by 224.80% while estimating it to be 12.60% for the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 30.59% during past 5 years.
CAPR Dividends
Capricor Therapeutics Inc is more likely to be releasing its next quarterly report between May 09 and May 13 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Capricor Therapeutics Inc (NASDAQ:CAPR)’s Major holders
Insiders are in possession of 9.19% of company’s total shares while institution are holding 21.69 percent of that, with stock having share float percentage of 23.89%. Investors also watch the number of corporate investors in a company very closely, which is 21.69% institutions for Capricor Therapeutics Inc that are currently holding shares of the company. Vanguard Group Inc is the top institutional holder at CAPR for having 1.17 million shares of worth $7.4 million. And as of Dec 30, 2023, it was holding 3.71% of the company’s outstanding shares.
The second largest institutional holder is Woodline Partners LP, which was holding about 0.91 million shares on Dec 30, 2023. The number of shares represents firm’s hold over 2.90% of outstanding shares, having a total worth of $5.78 million.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 30, 2023, the former fund manager was holding 0.77 million shares of worth $4.87 million or 2.44% of the total outstanding shares. The later fund manager was in possession of 0.35 million shares on Dec 30, 2023, making its stake of worth around $2.25 million in the company or a holder of 1.13% of company’s stock.
